Pharmafile Logo
Pharmafocus logo
Advanced Search

imnovid

Showing 5 posts of 5 posts found.

celgene_1_02

NICE u-turns on Celgene’s drug for multiple myeloma

November 24, 2016
Medical Communications Celgene, NICE, imnovid

NICE has performed a U-turn on Celgene’s Imnovid (pomalidomide) based on new data and the offer of a price reduction. …

News
celgene_1_02

Two Celgene cancer drugs approved in Ireland

March 1, 2016
Research and Development, Sales and Marketing Abraxane, Cancer, Celgene, Revlimid, imnovid

Irish regulators have recommended two cancer treatments from Celgene: Imnovid (pomalidomide), in combination with dexamethasone, for previously-treated relapsed and refractory …

News
NICE image

NICE decisions made on Bayer, Celgene and Boehringer drugs

March 26, 2015
Sales and Marketing Bayer, Boehringer, Celgene, NHS, Xarelto, imnovid, jardiance

In final guidance NICE has recommended Bayer’s Xarelto and Boehringer’s Jardiance for NHS funding, but not Celgene’s Imnovid. Bayer’s Xarelto …

News
Celgene image

Celgene’s blood cancer pill too expensive for NHS

February 13, 2015
Sales and Marketing Celgene, NHS, NICE, Pomalidomide, imnovid, myeloma

NICE has decided not to recommend Celgene’s Imnovid for treating patients with multiple myeloma – a cancer that affects white …

News
Celgene image

Scottish Medicines Consortium disappoints Celgene

July 8, 2014
Sales and Marketing Celgene, SMC, Scottish Medicines Consortium, imnovid, myeloma

Celgene admitted it is ‘disappointed’ with the Scottish Medicines Consortium decision not to recommend blood cancer therapy Imnovid for patients …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025